Illimis Therapeutics Company Profile, Contacts & Intelligence

Biotechnology ResearchKorea, Kr21 employeesFounded 2021
3 contacts with email or phone data3 with email data
View verified contacts Compare competitors
Employees
21
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts

Illimis Therapeutics Overview

Illimis Therapeutics is a platform-based Korean biotech company developing a chimeric fusion protein platform for neurodegenerative diseases such as Alzheimer’s. Our platform is differentiated by its ability to address the concerns of antibody-induced neuroinflammation and subsequent ARIA (Amyloid-Related Imaging Abnormalities) often observed from existing antibody drugs that utilize FcR-mediated phagocytosis of microglia, by utilizing TAM receptor, a novel phagocytic receptor expressed on the surface of glial cells.

Headquarters
Korea, Kr
Website
www.illimistx.com
Industry
Biotechnology Research
Founded
2021
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
IT Consulting

Illimis Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data in the visible sample.

Illimis Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

J
Jin Lee
Drug Development
E
C
Chan Hyuk Kim
Professor at Seoul National University
E
S
Sanghoon Park
Co-founder & CEO at Illimis Therapeutics
J
Jungu Bae
Head of R&D Strategy at Illimis
E

Illimis Therapeutics Workforce Composition

Seniority breakdown across 4 visible profiles.

Individual contributor
2
Executive
1
VP / Head
1

Compare Similar Companies to Illimis Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
뉴로핏 (Neurophet) It Services And It Consulting 73 View company
Everlab Health And Human Services 67 View company
One Biosciences Biotechnology Research 31 View company
SHIFTBIO INC. Biotechnology Research 22 View company
NUCLIDIUM AG Biotechnology Research 20 View company
DSC Investment Venture Capital And Private Equity Principals 19 View company
Innovation Office University of Basel Higher Education 19 View company
Neumirna Therapeutics Pharmaceutical Manufacturing 17 View company
LMNTIC Biotech Biotechnology Research 6 View company
Fortuga Bio Biotechnology Research Not listed View company